CURR - CURE Pharmaceutical Holding reports Q2 results September, 02 2022 06:05 AM Cure Pharmaceutical Holding Corp CURE Pharmaceutical Holding press release ( OTCQB:CURR ): Q2 Revenue of $1.6M (-23.8% Y/Y). "Gross margins increased and we expect the high margin sales to accelerate with our new marketing initiatives." For further details see: CURE Pharmaceutical Holding reports Q2 results